Diagnosticering av neuroborrelios baseras på en kombinerad bedömning av neurologiska symtom, serologiska tester för Borrelia-specifika antikroppar och analys av cerebrospinalvätska för att räkna antalet vita blodkroppar och mäta nivåer av kemokinet CXCL13. Nyligen publicerade studier har visat på att analys av IgM-antikroppar riktade mot Borrelia inte är ett lika starkt laboratoriestöd som analys av IgG-antikroppar. Analys av IgM-antikroppar har bidragit till högre antal falskt positiva svar på grund av ospecifik reaktivitet till andra patogener och persisterande antikroppar från tidigare infektioner. Syftet med denna studie var att utvärdera det diagnostiska värdet av att analysera IgM antikroppar i cerebrospinalvätska och serumprover för patienter med misstänkt neuroborrelios. Dessutom jämfördes prestandan mellan två kemiluminiscens immunanalyser, LIAISON (DiaSorin, Italy) och VirClia (Vircell, Spain). För utvärderingen analyserades 80 patientprover på laboratoriet för Klinisk Mikrobiologi på Länssjukhuset Ryhov i Jönköping, Sverige.  För att konfirmera positiva resultatet från de två kemiluminiscens immunanalyserna användes immunoblot, EUROLINE (EUROIMMUN, Germany). Sammanfattningsvis finns det inte tillräckligt med bevis att analys av IgM har ett tillräckligt diagnostiskt värde för att bekräfta en misstänkt neuroborrelios-diagnos. Jämförelsen mellan två kemiluminiscens immunanalyser visade att VirClia kan vara ett lämpligare alternativ än LIAISON när få prover analyseras. / The diagnosis of neuroborreliosis is based on a combined evaluation of neurological symptoms, serological tests for Borrelia-specific antibodies, cerebrospinal fluid analysis to measure white blood cell count and chemokine CXCL13 levels. Recently published data has shown that analysis of IgM antibodies against Borrelia is not as supportive in establishing a clinical diagnosis as IgG antibodies. IgM analysis has contributed to higher false-positive rates because of unspecific reactivities to other biological agents and persistent antibodies from prior infections.  The purpose of this study was to assess the diagnostic value of analysing IgM antibodies in cerebrospinal fluid and serum samples from patients with suspected neuroborreliosis. The performance of two chemiluminescent immunoassays, LIAISON (DiaSorin, Italy) and VirClia (Vircell, Spain), were compared as well. For this assessment, 80 patient samples were analysed at the Laboratory of Clinical Microbiology in Jönköping County, Sweden. Immunoblotting, EUROLINE (EUROIMMUN, Germany), was utilised to validate positive results from the chemiluminescent immunoassays. In conclusion, there is no convincing evidence to suggest that IgM analysis has sufficient diagnostic value to confirm a suspected diagnosis of neuroborreliosis. The comparison of two immunoassays showed that VirClia could be a valid alternative to LIAISON when analysing fewer samples at a time.

Die Kryptosporidiose stellt aufgrund ihres zoonotischen Charakters und der Entwicklung chronischer Durchfälle bei Immunsupprimierten ein hohes Gesundheitsrisiko für den Menschen, aber ebenso für Tiere dar. Derzeit verfügbare Therapeutika ermöglichen keine zuverlässige Bekämpfung klinischer Symptome oder eine Erregerelimination, daher ist die Erforschung neuer Therapieansätze dringend notwendig. CDPK stellen in diesem Zusammenhang interessante Zielmoleküle dar, da sie zwar in Pflanzen und Protisten einschließlich Apikomplexa, jedoch nicht in Pilzen und Säugetieren vorkommen. Trotz der Entdeckung vielversprechender neuer Wirkstoffe gegen CpCDPK1 in den letzten Jahren ist zur Lokalisation und Funktion von CDPK in C. parvum wenig bekannt.Diese Arbeit belegt die Transkription von sechs CpCDPK in vitro und beschreibt erstmals die Länge der 3’UTR von CpCDPK. Die Translation wurde durch den Nachweis spezifischen Proteins in Sporozoiten im Immunoblot sowie die Lokalisation von CpCDPK1 mit Hilfe der Immunfluoreszenz belegt. Möglicherweise wird die CpCDPK1 durch N-Myristoylierung an Membranen gebunden, an die Oberfläche von Zoiten gebracht und sezerniert. Eine Rolle des Enzyms im Invasions- und Egressmechanismus des Parasiten wird diskutiert.

Die humane Yersiniose wird durch Lebensmittel tierischen Ursprungs übertragen und stellt aufgrund der jährlich gleichbleibend hohen Zahl übermittelter Krankheitsfälle sowie der wahrscheinlich weitaus höheren Dunkelziffer ein Problem des gesundheitlichen Verbraucherschutzes dar. Die intermittierende Ausscheidung des Erregers Yersinia enterocolitica beim klinisch unauffälligen Reservoirtier Schwein und die aufwändige Kultivierung erschweren den direkten Erregernachweis. Hier könnte der serologische Nachweis, in der Humanmedizin bereits seit langem etabliert, eine wertvolle diagnostische Hilfe sein. Die Erkennung serologisch positiver Bestände ähnlich dem Salmonellen-Monitoring und daran anschließende Hygienemaßnahmen, vor allem vor und während der Schlachtung, können den Eintrag des Erregers in die Lebensmittelkette vermindern. So wurde im Rahmen dieser Arbeit ein hochspezifisches serologisches Nachweissystem entwickelt, das durch die Verwendung rekombinanter und ausschließlich bei pathogenen Yersinien vorkommender Antigene eine hohe Sensitivität und Spezifität garantiert. Neun ausgewählte Yersinia Outer Proteins (Yops) wurden kloniert und mit spezifisch auf jedes Protein abgestimmten Bedingungen zur optimalen Expression gebracht. Durch die Evaluierung verschiedener Aufreinigungssysteme konnten schließlich reproduzierbare hochreine Antigene auch in großen Mengen hergestellt werden. Mit Blick auf eine sichere Auswertbarkeit bei der Verwendung des Testsystems in Laboratorien wurden die Antigene nicht elektrophoretisch aufgebracht, sondern mittels Sprühverfahren auf eine Nitrozellulosemembran aufliniert. Das gebrauchsfertige Testsystem, Blotstreifen von 2,5 mm Breite mit neun auflinierten, rekombinant hergestellten und Virulenzplasmid-basierenden Yersinia-Antigenen, eignet sich zur Diagnostik serologisch positiver Schweine. Mit Hilfe dieses Testsystems wurde die isotypspezifische Antikörperantwort von Schweinen im Infektionsmodell gegen den Erreger Y. enterocolitica ausgewertet. Nach zwei Vorversuchen mit jeweils zwei Schweinen wurden im Hauptversuch neun Ferkel experimentell mit einer Infektionsdosis von 5x1011 KBE per Magenschlundsonde infiziert, wobei die Tiere nach leichtem und kurzfristigem Durchfallgeschehen den Erreger symptomlos mit dem Kot ausschieden. Weitere neun Ferkel stellten eine Kontrollgruppe nicht infizierter Tiere dar. Vom Tag der Infektion bis zum Tag der Tötung (Tag 33) wurde regelmäßig bei den achtzehn Schweinen Blut, Speichel und Tränenflüssigkeit gewonnen, am letzten Tag zusätzlich Gelenkflüssigkeit und Darmsekrete. Die Auswertung der Seren im zeitlichen Verlauf zeigte deutlich die Immunogenität der Yops. Bei dominierenden Yops wie YopO, YopH, LcrV, YopD und YopE ließ sich das Einsetzen der Antikörperbildung (IgG und IgA) mit nachfolgendem Anstieg bei allen infizierten Tieren feststellen. Die früheste Bildung von Immunglobulin G konnte am Tag 10 gegen YopD verzeichnet werden, Immunglobulin A wurde gegen YopD bereits am Tag 7 gebildet. Die nicht infizierten Kontrolltiere waren im Immunoblot durchgehend negativ. In den Darmsekreten, der Gelenk- und Tränenflüssigkeit und vor allem im Speichel liessen sich mit dem entwickelten Test ebenfalls spezifische Yop- Antikörper detektieren. Der Test kann somit zur Diagnostik von Beständen mit Yersinia-Problematik herangezogen werden; er eignet sich als kompletter Kit sowohl für Labore als auch für veterinärmedizinische Praxen.

Darmstadt, Techn. Univ., Diss., 2001. / Dateiformat: tar.gz, Dateien im PDF-Format

O diagnóstico da infecção pelo vírus da hepatite C (HCV) é obtido através de testes de triagem para anti-HCV pelo ELISA e para confirmar os positivos, por teste suplementar mais específico, o immunoblot (IB). A infecção ativa é determinada pelas técnicas moleculares como por exemplo a PCR. Os testes sorológicos são métodos indiretos, baseados na detecção de anticorpos específicos, estando portanto, sujeito a vários fatores que limitam a sua eficiência diagnóstica, podendo gerar resultados inespecíficos. Um dos objetivos deste trabalho foi o de avaliar a eficiência diagnóstica dos testes para o diagnóstico da infecção pelo HCV, em condições de rotina diagnóstica, em um grande número de amostras de doadores de sangue e analisar o custo benefício de três diferentes algoritmos, recentemente propostos pelo Centro de Controle de Doenças e Prevenção (EUA). Foram estudadas 692 amostras de soros provenientes de doadores de sangue, sendo 522 positivas e 170 inconclusivas pelo ELISA de triagem (ELlSA-T) realizado no momento da doação. Esses doadores retornaram à Fundação PróSangue/ Hemocentro de São Paulo para a coleta da segunda amostra de sangue para confirmação dos resultados obtidos na doação. Em todas as amostras de retorno foram realizadas ELISA (ELISA-R) e a PCR, o IB somente nas positivas ou indeterminadas no ELISA-R. A concordância global de resultados entre ELlSA-T e ELlSA-R foi de 64,5%, sendo 77,6% (405/522) entre os positivos e 24,1 % (41/170) entre os inconclusivos. Em amostras positivas nos dois ELlSAs, o IB foi positivo (aqui denominadas de sorologicamente positivas) em 69,6% (282/405) e PCR em 61,2% (248/405). Entre as 282 amostras sorologicamente positivas, viremia foi detectada em 87,6% (247/282). A ausência de viremia em 12,4% (37/282) dessas amostras pode representar amostras de indivíduos que tiveram a infecção no passado e que eliminaram espontaneamente o HCV. A avaliação de bandas individuais no IB mostrou a alta freqüência das bandas do core (C1C2 e C3C4). Entretanto sua distribuição entre as amostras de doadores virêmicos e não virêmicos foi bastante semelhante. A intensidade da reação, expressa como graduação da coloração das bandas no IB, demonstrou que C1C2 e NS3 fortemente reativas eram as mais associadas à positividade no IB e na PCR e a banda NS4 somente com a PCR. A análise dos resultados do teste de ELISA anti-HCV de doadores de sangue indicou que a relação DO/CO, aqui denominada de índice de reatividade (IR), poderia ser utilizada como preditivo de positividade no teste suplementar. O IR de todas as amostras foram estratificados em 6 grupos sendo o IR &#8805; 6 o que melhor correlacionou-se com a positividade no IB (IR de corte). Os três algoritmos para o diagnóstico da infecção pelo HCV, propostos pelo CDC foram avaliados, sendo dois novos (a e b) e o outro, o algoritmo convencional (c). a) Resultados de ELISA com IR &#8805; 6,0 é considerado positivo sem a necessidade de teste suplementar. Para amostras IR < 6,0, de preferência o IB, seria realizado; b) Teste molecular (NAT) deve ser feito para todas as amostras positivas no teste de triagem, seguido de IB naquelas negativas no NAT; c) IB realizado para todas as amostras positivas na triagem. Esses algoritmos foram aplicados em todas as amostras, com resultados muito semelhantes entre si: 287, 287 e 285 positivos, respectivamente para a, b e c. Um total de 283 amostras foi positivo nos três algoritmos e quatro, com resultados divergentes, foram analisadas separadamente. A análise do custo benefício mostrou que o algoritmo a é o mais econômico e prático podendo ser recomendado para os laboratórios com condições econômicas limitadas; o b é o mais completo para fins de decisão médica, fornecendo informações precoces sobre a presença ou a ausência da viremia; o c é importante para determinar o status imunológico e para a população de baixa prevalência da infecção pelo HCV. O custo estimado dos três algoritmos baseou-se na tabela de 2004 da Associação Médica Brasileira. Esses custos mostraram ser o algoritmo a, 40% mais econômico e o b, 18,2% mais oneroso do que o c. Os algoritmos a e c foram complementados pela realização da PCR, nas amostras indeterminadas provenientes desses algoritmos. Duas amostras resultaram em PCR positivas, as mesmas já consideradas positivas inicialmente pelo algoritmo b. Os três algoritmos estudados, puderam ser validados para o diagnóstico laboratorial da infecção pelo HCV, podendo a escolha depender do interesse clínico ou da prevalência dessa infecção na população. / The diagnosis of hepatitis C (HCV) infection is usually undertaken stepwise by screening with ELISA and confirming the positive results in screening with a more specific assay, the immunoblot (IB). Active infection by hepatitis C virus should be confirmed by molecular techniques such as PCR. Serological tests are indirect methods based on specific antibody detection. Therefore, they may be influenced by many factors which limit their diagnostic efficiency, producing false-positive results. The aim of this work was to evaluate the real diagnostic efficiency of anti-HCV screening tests, in routine condition, in a large serum sampling, and to analyze the cost-benefit of three different algorithms recently proposed by the Center for Diseases Control and Prevention. 692 serum samples were studied. The samples consisted of 522 sera from blood donors, positive in ELISA, with the sample collected by the time of donation (ELlSA-T), and of 170 inconclusive sera. Those donors returned to Fundação PróSangue Hemocentro de São Paulo to have a second sample of blood collected to confirm the former results. ELlSA-R and PCR were carried out in all second samples and all the positive and inconclusive samples were submitted to IB. The global concordance of results between ELlSA-T and ELlSA-R was 64,5%, in that 77,6%(405/522) were obtained among the positives results and 24,1% (41/170) among inconclusive. For samples positive in both ELlSAs, IB was positive (serologically positive) in 69,6% (282/405) and PCR in 61,2% (248/405). Among 282 serologically positive samples, viremia was detected in 87,6% (247/282) and it was absent in 12,4% (37/282) of the sera, which could represent samples from individuals who were infected by HCV in the past and who have spontaneously cleared the virus. Evaluation of each antigenic band of IB showed high frequency of core (C1C2 and C3C4). Their distribution among viremic and non-viremic donors was similar. The reaction intensity, expressed by the color score of the bands, demonstrated that the strongly reactive bands of C1C2 and NS3 were associated with positiveness in IB and PCR and of NS4 only with PCR positive. Analysis of anti-HCV ELISA results from blood donors indicated that the signal-to-cut-off ratio (DO/CO), named as reactive index (IR) in this study, could be used to predict supplemental test positive results for anti-HCV. IR from all samples was classified in 6 groups, being IR &#8805; 6, the index better correlated with positive on IB (cut-off IR). The CDC has recently proposed three algorithms for HCV diagnosis, in which two were new (a and c) and one was a conventional algorithm (c). a) screening-test-positive samples with IR &#8805; 6,0 can be reported as anti-HCV positive without supplemental testing. IR < 6,0 should have refiex supplemental testing performed, preferably IB; b) reflex supplemental testing in all specimens screening-test-positive by performing NAT followed by IB for specimens with NAT negative results; c) reflex supplemental testing (IB) in all specimens screening-test-positive. These algorithms were applied to all samples and resulted in very similar positive results: 287, 287 and 285, respectively for a, b and c. A total of 283 samples were positive in three algorithms. Four samples showed divergent results and were analyzed separately. Cost-benefit - The algorithm a is the most economical and practical and it could be recommended for laboratory with limited conditions and for population with a high prevalence of HCV infection; b is the most complete for medical decision providing early information about the presence or absence of viremia; c is suitable for determining immune status and for HCV infection low prevalence population. The cost of the three algorithms was estimated based on the 2004 Brazilian Medical Association Table. These costs were 40% lower than c for algorithm a, and 18,2% higher for b. The algorithm a and c were complemented by performing PCR to solve indeterminate results. This complementary test detected two samples PCR positive which were already positive by algorithm b. Therefore we could validate those algorithms for HCV infection laboratory diagnosis. Laboratories and blood banks may choose the algorithm depending on the clinical interest or on the prevalence of HCV infection in the population.

O diagnóstico da infecção pelo vírus da hepatite C (HCV) é obtido através de testes de triagem para anti-HCV pelo ELISA e para confirmar os positivos, por teste suplementar mais específico, o immunoblot (IB). A infecção ativa é determinada pelas técnicas moleculares como por exemplo a PCR. Os testes sorológicos são métodos indiretos, baseados na detecção de anticorpos específicos, estando portanto, sujeito a vários fatores que limitam a sua eficiência diagnóstica, podendo gerar resultados inespecíficos. Um dos objetivos deste trabalho foi o de avaliar a eficiência diagnóstica dos testes para o diagnóstico da infecção pelo HCV, em condições de rotina diagnóstica, em um grande número de amostras de doadores de sangue e analisar o custo benefício de três diferentes algoritmos, recentemente propostos pelo Centro de Controle de Doenças e Prevenção (EUA). Foram estudadas 692 amostras de soros provenientes de doadores de sangue, sendo 522 positivas e 170 inconclusivas pelo ELISA de triagem (ELlSA-T) realizado no momento da doação. Esses doadores retornaram à Fundação PróSangue/ Hemocentro de São Paulo para a coleta da segunda amostra de sangue para confirmação dos resultados obtidos na doação. Em todas as amostras de retorno foram realizadas ELISA (ELISA-R) e a PCR, o IB somente nas positivas ou indeterminadas no ELISA-R. A concordância global de resultados entre ELlSA-T e ELlSA-R foi de 64,5%, sendo 77,6% (405/522) entre os positivos e 24,1 % (41/170) entre os inconclusivos. Em amostras positivas nos dois ELlSAs, o IB foi positivo (aqui denominadas de sorologicamente positivas) em 69,6% (282/405) e PCR em 61,2% (248/405). Entre as 282 amostras sorologicamente positivas, viremia foi detectada em 87,6% (247/282). A ausência de viremia em 12,4% (37/282) dessas amostras pode representar amostras de indivíduos que tiveram a infecção no passado e que eliminaram espontaneamente o HCV. A avaliação de bandas individuais no IB mostrou a alta freqüência das bandas do core (C1C2 e C3C4). Entretanto sua distribuição entre as amostras de doadores virêmicos e não virêmicos foi bastante semelhante. A intensidade da reação, expressa como graduação da coloração das bandas no IB, demonstrou que C1C2 e NS3 fortemente reativas eram as mais associadas à positividade no IB e na PCR e a banda NS4 somente com a PCR. A análise dos resultados do teste de ELISA anti-HCV de doadores de sangue indicou que a relação DO/CO, aqui denominada de índice de reatividade (IR), poderia ser utilizada como preditivo de positividade no teste suplementar. O IR de todas as amostras foram estratificados em 6 grupos sendo o IR &#8805; 6 o que melhor correlacionou-se com a positividade no IB (IR de corte). Os três algoritmos para o diagnóstico da infecção pelo HCV, propostos pelo CDC foram avaliados, sendo dois novos (a e b) e o outro, o algoritmo convencional (c). a) Resultados de ELISA com IR &#8805; 6,0 é considerado positivo sem a necessidade de teste suplementar. Para amostras IR < 6,0, de preferência o IB, seria realizado; b) Teste molecular (NAT) deve ser feito para todas as amostras positivas no teste de triagem, seguido de IB naquelas negativas no NAT; c) IB realizado para todas as amostras positivas na triagem. Esses algoritmos foram aplicados em todas as amostras, com resultados muito semelhantes entre si: 287, 287 e 285 positivos, respectivamente para a, b e c. Um total de 283 amostras foi positivo nos três algoritmos e quatro, com resultados divergentes, foram analisadas separadamente. A análise do custo benefício mostrou que o algoritmo a é o mais econômico e prático podendo ser recomendado para os laboratórios com condições econômicas limitadas; o b é o mais completo para fins de decisão médica, fornecendo informações precoces sobre a presença ou a ausência da viremia; o c é importante para determinar o status imunológico e para a população de baixa prevalência da infecção pelo HCV. O custo estimado dos três algoritmos baseou-se na tabela de 2004 da Associação Médica Brasileira. Esses custos mostraram ser o algoritmo a, 40% mais econômico e o b, 18,2% mais oneroso do que o c. Os algoritmos a e c foram complementados pela realização da PCR, nas amostras indeterminadas provenientes desses algoritmos. Duas amostras resultaram em PCR positivas, as mesmas já consideradas positivas inicialmente pelo algoritmo b. Os três algoritmos estudados, puderam ser validados para o diagnóstico laboratorial da infecção pelo HCV, podendo a escolha depender do interesse clínico ou da prevalência dessa infecção na população. / The diagnosis of hepatitis C (HCV) infection is usually undertaken stepwise by screening with ELISA and confirming the positive results in screening with a more specific assay, the immunoblot (IB). Active infection by hepatitis C virus should be confirmed by molecular techniques such as PCR. Serological tests are indirect methods based on specific antibody detection. Therefore, they may be influenced by many factors which limit their diagnostic efficiency, producing false-positive results. The aim of this work was to evaluate the real diagnostic efficiency of anti-HCV screening tests, in routine condition, in a large serum sampling, and to analyze the cost-benefit of three different algorithms recently proposed by the Center for Diseases Control and Prevention. 692 serum samples were studied. The samples consisted of 522 sera from blood donors, positive in ELISA, with the sample collected by the time of donation (ELlSA-T), and of 170 inconclusive sera. Those donors returned to Fundação PróSangue Hemocentro de São Paulo to have a second sample of blood collected to confirm the former results. ELlSA-R and PCR were carried out in all second samples and all the positive and inconclusive samples were submitted to IB. The global concordance of results between ELlSA-T and ELlSA-R was 64,5%, in that 77,6%(405/522) were obtained among the positives results and 24,1% (41/170) among inconclusive. For samples positive in both ELlSAs, IB was positive (serologically positive) in 69,6% (282/405) and PCR in 61,2% (248/405). Among 282 serologically positive samples, viremia was detected in 87,6% (247/282) and it was absent in 12,4% (37/282) of the sera, which could represent samples from individuals who were infected by HCV in the past and who have spontaneously cleared the virus. Evaluation of each antigenic band of IB showed high frequency of core (C1C2 and C3C4). Their distribution among viremic and non-viremic donors was similar. The reaction intensity, expressed by the color score of the bands, demonstrated that the strongly reactive bands of C1C2 and NS3 were associated with positiveness in IB and PCR and of NS4 only with PCR positive. Analysis of anti-HCV ELISA results from blood donors indicated that the signal-to-cut-off ratio (DO/CO), named as reactive index (IR) in this study, could be used to predict supplemental test positive results for anti-HCV. IR from all samples was classified in 6 groups, being IR &#8805; 6, the index better correlated with positive on IB (cut-off IR). The CDC has recently proposed three algorithms for HCV diagnosis, in which two were new (a and c) and one was a conventional algorithm (c). a) screening-test-positive samples with IR &#8805; 6,0 can be reported as anti-HCV positive without supplemental testing. IR < 6,0 should have refiex supplemental testing performed, preferably IB; b) reflex supplemental testing in all specimens screening-test-positive by performing NAT followed by IB for specimens with NAT negative results; c) reflex supplemental testing (IB) in all specimens screening-test-positive. These algorithms were applied to all samples and resulted in very similar positive results: 287, 287 and 285, respectively for a, b and c. A total of 283 samples were positive in three algorithms. Four samples showed divergent results and were analyzed separately. Cost-benefit - The algorithm a is the most economical and practical and it could be recommended for laboratory with limited conditions and for population with a high prevalence of HCV infection; b is the most complete for medical decision providing early information about the presence or absence of viremia; c is suitable for determining immune status and for HCV infection low prevalence population. The cost of the three algorithms was estimated based on the 2004 Brazilian Medical Association Table. These costs were 40% lower than c for algorithm a, and 18,2% higher for b. The algorithm a and c were complemented by performing PCR to solve indeterminate results. This complementary test detected two samples PCR positive which were already positive by algorithm b. Therefore we could validate those algorithms for HCV infection laboratory diagnosis. Laboratories and blood banks may choose the algorithm depending on the clinical interest or on the prevalence of HCV infection in the population.

Die Kryptosporidiose stellt aufgrund ihres zoonotischen Charakters und der Entwicklung chronischer Durchfälle bei Immunsupprimierten ein hohes Gesundheitsrisiko für den Menschen, aber ebenso für Tiere dar. Derzeit verfügbare Therapeutika ermöglichen keine zuverlässige Bekämpfung klinischer Symptome oder eine Erregerelimination, daher ist die Erforschung neuer Therapieansätze dringend notwendig. CDPK stellen in diesem Zusammenhang interessante Zielmoleküle dar, da sie zwar in Pflanzen und Protisten einschließlich Apikomplexa, jedoch nicht in Pilzen und Säugetieren vorkommen. Trotz der Entdeckung vielversprechender neuer Wirkstoffe gegen CpCDPK1 in den letzten Jahren ist zur Lokalisation und Funktion von CDPK in C. parvum wenig bekannt.Diese Arbeit belegt die Transkription von sechs CpCDPK in vitro und beschreibt erstmals die Länge der 3’UTR von CpCDPK. Die Translation wurde durch den Nachweis spezifischen Proteins in Sporozoiten im Immunoblot sowie die Lokalisation von CpCDPK1 mit Hilfe der Immunfluoreszenz belegt. Möglicherweise wird die CpCDPK1 durch N-Myristoylierung an Membranen gebunden, an die Oberfläche von Zoiten gebracht und sezerniert. Eine Rolle des Enzyms im Invasions- und Egressmechanismus des Parasiten wird diskutiert.

The goal of this study was to map the glycosylation pattern and antigenic properties of the salivary proteins of two closely related sand fly species, Phlebotomus perniciosus and P. orientalis. Affinity blotting with commercially available lectins revealed that many salivary proteins of these species are N-glycosylated, while the presence of O-glycosylation could not be confirmed. The level of N-glycosylation of most of these proteins is quite low, a larger number of potential N-glycosylation sites were found only in the amino acid sequences of P. orientalis hyaluronidase and endonucleases of both species tested. Four antigens from P. perniciosus salivary glands were selected for expression in a bacterial expression system; two of these proteins (PpeSP01 and PpeSP01B) were not glycosylated and the glycosylation level of the remaining two (PpeSP03B and PpeSP07) was low. The antigenic properties of the four chosen recombinant proteins were subsequently tested using immunoblot and ELISA. During the initial experiments with the sera of dogs experimentally bitten by P. perniciosus, two proteins (rSP07 and rSP01B) were proven unsuitable and they were excluded from further experiments. Recombinant proteins rSP03B and rSP01 were recognized by the same IgG antibodies as the native forms of these proteins...

Phosducin-like Protein existiert in zwei Splicevarianten: PhLPLONG (PhLPL) und PhLPSHORT (PhLPS). Sie unterscheiden sich in der Länge ihres N-Terminus und in ihrem Expressionsmusters: Die lange Form (PhLPL) wird ubiquitär exprimiert und bindet G-Protein-betagamma-Untereinheiten (Gbetagama), was zur Hemmung von Gbetagamma-abhängigen Funktionen führt. Der um 83 Aminosäuren verlängerte N-Terminus besitzt ein hoch konserviertes Motiv, welches für die Gbetagamma-Bindung und Regulation von entscheidender Bedeutung ist. Im Gegensatz hierzu besitzt die kurzen Spliceform PhLPS, deren Expression in verschiedenen Gewebetypen deutlich geringer ist, diese hoch konservierte Region nicht. In der vorliegenden Arbeit wurde nun erstmals die Rolle von PhLPL und PhLPS bei der Gbetagamma-Regulation in intakten Zellen untersucht. Hierbei konnte überraschenderweise gefunden werden, dass PhLPS der potentere und effizientere Regulator für Gbetagamma-abhängige Signale war. PhLPL hingegen schien in seiner Gbetagamma-regulierenden Fähigkeit limitiert zu werden. Die Ursache dieser Limitierung von PhLPL in intakten Zellen wurde auf eine konstitutive Phosphorylierung seines verlängerten N-Terminus durch die ubiquitäre Casein Kinase 2 (CK2) zurückgeführt. Die verantwortlichen Phosphorylierungsstellen (S18, T19, S20) wurde identifiziert und die Mutation der CK2-Phosphorylierungsstellen (PhLPLA18-20) führte zu einer Verbesserung der hemmenden Funktion von PhLPL in Zellen. In vitro-Assays zur Bindungsfähigkeit von rekombinantem PhLPL (vor und nach CK2-Phosphorylierung) zeigten allerdings: die Phosphorylierung beeinflusste die Affinität nicht. Eine genaue Analyse der N-terminalen Strukuren von PhLPL zeigte indes, dass die Regulationsfähigkeit von PhLPL in intakten Zellen vor allem in dem konservierten Gbetagamma-Bindungsmotiv zu suchen war. Die Mutation einer einzigen Aminosäure (W66V) war ausreichend, um sowohl die Gbetagamma-Bindungsfähigkeit, als auch die Fähigkeit zur funktionellen Hemmung in intakten Zellen zu verlieren. Was war also der Mechanismus der Hemmung von Gbetagamma durch PhLPS und die phophorylierungsdefiziente Mutante von PhLPL? Ein erster Hinweis hierauf kam von der Beobachtung, dass die Gbeta- und Ggamma-Untereinheiten in Anwesenheit von PhLPS in ihrem Proteingehalt deutlich reduziert vorlagen (wie in Western Blots gezeigt). Dieser Mechanismus schien von proteasomalen Abbauwegen abzuhängen (gezeigt durch Effekte des spezifischen Proteasominhibitors Lactazystin). Allerdings schien eine Stabilisierung der Gbeta- und Ggamma-Untereinheiten (durch N-terminale Fusion mit einem Protein zur vitalen Proteinfärbung) nicht die Funktionsfähigkeit von Gbetagamma in Anwesenheit von PhLPS bewahren zu können. Ganz im Gegenteil, es wurde gezeigt, dass Gbeta und Ggamma hierbei nicht mehr zu einem funktionellen Dimer assoziierten. Dies war ein Hinweis darauf, dass möglicherweise Proteinfaltungsmechanismen bei der Regulation essentiell sein könnten. Eine postulierte Rolle bei der Faltung von WD40-Repeatproteinen wie der Gbeta-Untereinheit wurde dem Chaperonin-Komplex CCT (chaperonin containing TCP) zugedacht. Folgerichtig konnte PhLPS mit seinen funktionell aktiven Domänen an endogenes TCP-1alpha (einer Untereinheit von CCT) binden. Ferner konnte gezeigt werden, dass die Hemmung des CCT-Komplexes durch RNA-Interferenz mit TCP-1alpha ebenso wie PhLPS zur spezifischen Reduktion von Gbetagamma führte. In dieser Arbeit wurde also ein neuartiger Mechanismus der G-Protein-Regulation durch Hemmung der Proteinfaltung von Gbetagamma beschrieben. Ein Schaltmechanismus zwischen direkter Gbetagamma-Bindung (induziert durch CK2-Phosphorylierung von PhLPL) und Hemmung der Proteinfaltung von Gbetagamma (induziert durch alternatives Splicen oder durch Dephosphorylierung von PhLP) wird postuliert. / Phosducin-like protein (PhLP) exists in two splice variants PhLPLONG (PhLPL) and PhLPSHORT (PhLPS): They differ in the length of their N-termini and their expression pattern: The long form (PhLPL) is a ubiquitously expressed protein and binds G-protein betagamma-subunits (Gbetagamma) and thereby inhibits Gbetagamma-mediated function. The extended N-terminus of PhLPL (83 amino acids) contains a highly conserved Gbetagamma-binding motif which plays the crucial role in binding and regulating Gbetagamma-subunits. In contrast, the short splice variant PhLPS, which has a more restricted expression, lacks this motif and did not seem to exert a major Gbetagamma-inhibition, when tested with purified proteins. In the present work, for the first time, we investigated the Gbetagamma-inhibiting properties of PhLPL and PhLPS in intact cells. Surprisingly, PhLPS was the more potent and effective Gbetagamma inhibitor, while PhLPL was limited in this respect. The reason for the limited ability to inhibit Gbetagamma in intact cells was found in a constitutive phosphorylation by the ubiquitious kinase casein kinase 2 (CK2). The responsible phosphorylation sites could be identified (S18, T19, S20) and mutation of those sites into alanines could ameliorate the function of PhLPL. We therefore hypothesised that CK2 dependent phosphorylation of PhLPL should reduce binding affinity towards Gbetagamma subunits. But instead, direct phosphorylation of recombinant PhLPL by CK2 did not reduce its binding affinites. A thorough analysis of the N terminus of PhLPL revealed that a single mutation of the conserved N terminal binding motif (W66V) was sufficient to ablate Gbetagamma binding and Gbetagamma inhibition in intact cells. A first hint to an alternative mechanism came from the observation that - in the presence of PhLPS - the protein content of Gbeta and Ggamma subunits was dramatically reduced (as determined by Western blotting). This phenomenon seemed to be dependent on a proteasomal pathway (which was shown by effects of the specific proteasome inhibitor lactacystine). But a stabilization of the Gbeta and Ggamma subunits through N terminal fusion of a dye-labeling protein could not restore the function of Gbetagamma in the presence of PhLPS. Instead, it could be demonstrated that under these conditions Gbeta and Ggamma did not form functional dimers any more. This finding led to the conclusion that a protein folding mechanism was possibly involved. A postulated role in the folding of WD40 repeat proteins (like the Gbeta subunit) was assumed for the cytosolic chaperonin complex CCT in the literature. PhLPS was able to bind to TCP-1alpha, a subunit of CCT, as were the functionally active domains of PhLPS. We further demonstrated that the inhibition of CCT by RNA interference with TCP-1alpha also led to down-regulation of Gbeta and Ggamma subunits. So, in this thesis, a novel mechanism of G-protein regulation through inhibition of Gbetagamma protein folding was described. Further, a switch mechanism between direct Gbetagamm binding (induced by phosphorylation of PhLPL) and inhibition of Gbetagamm folding (induced by alternative splicing or dephosphorylation of PhLP) is postulated.

Sete suínos com 2 meses de idade foram infectados experimentalmente com cerca de 200.000 ovos de T. solium administrados por via oral. Ao término do experimento (140 dias) os animais não apresentaram aspectos clínicos de cisticercose pelo exame de inspeção da língua; portanto eles poderiam ser classificados como animais saudáveis pelos exames usuais de inspeção utilizados em matadouros. Todos os animais foram sacrificados e a musculatura, cérebro e órgãos viscerais foram seccionados em finos pedaços para a procura de cistos. O número de cisticercos encontrados em cada animal variou de 1 a 85 (média 33,7 e desvio padrão 31,3), caracterizando-os como animais com infecção branda. Amostras de sangue dos animais infectados experimentalmente foram submetidas a imunoensaios para a pesquisa de anticorpos (ELISA Indireto, utilizando como antígeno o líquido vesicular de Taenia crassiceps; imunoblot 18/14, oriundo de antígeno de Taenia crassiceps purificado com anticorpos monoclonais e imunoblot LLGP, utilizando glicoproteínas de T. solium purificadas com lentil lectina) e para pesquisa de antígeno (ELISA Sanduíche e ELISA Direto, ambos utilizando o anticorpo monoclonal anti-ES-Tcra). O teste ELISA Direto não apresentou reatividade em qualquer amostra de soro dos diferentes animais infectados no momento do abate (t140). Foi encontrada positividade de 71% e 57%, respectivamente, para os testes ELISA Indireto para a pesquisa de anticorpos e ELISA Sanduíche para a pesquisa de antígenos nestes tempos. Pelo imunoblot (IB) 18/14 e IB LLGP, respectivamente 5 (71 %) e 6 (86%) dos animais infectados experimentalmente foram positivos no t140. O uso de ensaios imunoenzimáticos para a detecção de anticorpos específicos (IB) somados ao ELISA Sanduíche para pesquisa de antígeno permitiu que todos os animais com infecção branda fossem detectados. Dessa forma, o uso de ensaios imunoenzimáticos para detecção de anticorpos e/ou antígenos mostrou-se mais útil que o exame clínico e/ou post-mortem para a triagem de cisticercose suína em animais com infecção branda. / Seven 2-month-old swine were orally experimentally infected with approximately 200,000 eggs of Taenia solium. At the end of the experiment (140 days) the animals did not show clinical aspects of cysticercosis or parasites in tongue inspection; therefore they could be mistaken as healthy animals by usual inspection exams used in slaughterhouses. All of them were slaughtered and their whole muscles, brain and visceral organs were cut into thin slices searching for cysts. The number of cysts found in each animal varies from 1 to 85 (mean value 33.7 and standard deviation 31.3) characterizing them as slightly infected animals. Blood samples of experimentally infected animals were submitted to immunoassays for antibody detection (Indirect ELISA, using vesicular fluid antigen from Taenia crassiceps; immunoblot 18/14, from T.crassiceps antigen purified by monoclonal antibodies and immunoblot LLGP, using lentil lectin purified glycoproteins of T. solium) and for antigen detection (Sandwich ELISA and Direct ELISA, both using monoclonal antibodies anti-ES-Tcra). The Direct ELISA assay did not show any reactivity with all serum samples from the different animals at the slaughtered moment (t140). The positivity was 71% and 57% by the Indirect ELISA for searching antibodies and by the Sandwich ELISA for searching antigens, respectively. By immunoblot (IB) 18/14 and IB LLGP 5 (71 %) and 6 (86%) experimentally infected animals were positive at t140, respectively. The use of immunoassays for detecting specific antibodies (IB) together with Sandwich ELISA for antigen detection allow the detection of all slightly infected animals. Thus, the use of immunoassays for antibodies and/or antigen detection showed they are more useful than usual clinical examination and/or tongue palpation for screening cysticercosis in slightly infected pigs.